IndraLab

Statements


USP13 deubiquitinates SIGIRR. 1 / 1
1 |

"Stabilization of IL-1R8/Sigirr by USP13 describes a novel anti-inflammatory pathway in diseases that could provide a new strategy to modulate immune activation."